CNP
52
-7
IBM
51
-2
HPE
44
-4
MAC
51
-2
LLY
45
8
STX
38
4
WMB
60
2
BSX
67
3
WEC
39
3
EQT
50
3
JCI
42
-2
DG
12
-2
SRE
40
3
CSCO
66
3
CI
38
3
CVX
14
-11
VRTX
47
2
CINF
35
11
AMAT
41
6
ISRG
66
2
CNP
52
-7
IBM
51
-2
HPE
44
-4
MAC
51
-2
LLY
45
8
STX
38
4
WMB
60
2
BSX
67
3
WEC
39
3
EQT
50
3
JCI
42
-2
DG
12
-2
SRE
40
3
CSCO
66
3
CI
38
3
CVX
14
-11
VRTX
47
2
CINF
35
11
AMAT
41
6
ISRG
66
2
Financhill
Back

Immuneering 10K Form

Sell
48

IMRX
Immuneering

Last Price:
$2.22
Seasonality Move:
-14.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMRX News And Ratings

See the #1 stock for the next 7 days that we like better than IMRX

IMRX Financial Statistics

Sales & Book Value

Annual Sales: $317K
Cash Flow: $-13.5M
Price / Cash Flow: 0
Annual Sales: $1.86
Price / Book: 1.18

Profitability

EPS (TTM): -1.97000
Net Income (TTM): $-58.1M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Immuneering Earnings Forecast

Key Immuneering Financial Ratios

  • The Selling, General & Administrative Expenses for IMRX have been equal to 4,924.12% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Immuneering Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMRX
Website: immuneering.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMRX Technical Analysis vs Fundamental Analysis

Sell
48
Immuneering (IMRX) is a Sell

Is Immuneering a Buy or a Sell?

  • Immuneering stock is rated a Sell
    The current Immuneering [IMRX] share price is $2.20. The Score for IMRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.